Laurel Wealth Advisors (California)’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Laurel Wealth Advisors (California)'s LLY Position: Q4 2022 in Review
Laurel Wealth Advisors (California) increased its Eli Lilly (LLY) stake by 2.7% in Q4 2022, buying an estimated $52.8K and bringing the position to 5,745 shares worth $2.1M. The position accounts for 0.21% of the portfolio, ranked #115.
Laurel Wealth Advisors (California) first reported a position in LLY in Q4 2015 and has held it in 29 quarters since. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.
- Laurel Wealth Advisors (California) held 5,745 shares of Eli Lilly worth $2.1M as of Q4 2022.
- Laurel Wealth Advisors (California) bought 149 Eli Lilly shares in Q4 2022, an estimated $52.8K.
- Eli Lilly made up 0.21% of Laurel Wealth Advisors (California)'s portfolio in Q4 2022, its #115 holding.
- Laurel Wealth Advisors (California) first reported a position in Eli Lilly in Q4 2015 and has held it in 29 quarters since.
- 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.
Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2022, filed 14 Feb 2023.